Endometriosis Treatment Market

Endometriosis Treatment Market: Launch of Novel GnRH Analogues Anticipated to Substitute Oral Contraceptive Prescriptions: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

Ask The Analyst Customization Available Request Methodology

Growing Prescription of GnRH Analogues

GnRH analogues are mostly prescribed as a second-line treatment option for the endometriosis condition. Physicians usually recommend them for six months. Though the product is gaining traction from the manufacturers’ end, the most important product for endometriosis treatment, which got FDA approval, is elagolix. With a brand name Orilissa, elagolix is a gonadotropin-releasing hormone antagonist (GnRH antagonist). This product in endometriosis treatment is estimated to grow the market share of GnRH analogues by itself. Similar GnRH analogues are also used to treat advanced prostate cancer. Bruserelin, goserelin, and leuprolide are few examples of GnRH analogues used for both cases of endometriosis treatment and prostate cancer. It makes this endometriosis treatment market more dynamic in nature, as new manufacturers take interest in the production of medicines that cover a broad range of diseases. These allow them to have a more flexible production scenario and target population.

The use of such analogues in cancer care helps in understanding the growth and acceptance of endometriosis treatment, as most drugs are sold off-label in the endometriosis treatment market.

Rising Prevalence of Endometriosis Conditions

Endometriosis affects a large number of women who are in their reproductive age. It is estimated to have a prevalence rate of 1 in 10 among women in the reproductive age group. The number is rising with the growing population count in that age range. Though there isn’t a complete cure for this condition, effective endometriosis treatment is provided through medication which suppresses the extreme pain suffered during endometriosis. There are many assumptions to be taken in order to estimate the correct prevalence of endometriosis patients. The absolute prevalent population is always limited as most cases in developing regions are not reported. Also, the awareness and understanding of different scales of pain is very limited in most regions. Hence, cases of endometriosis often get ignored. The situation persists in not only developing or poor socio-economic countries, but developed countries like the UK, where it is assumed that around 2 million women have undiagnosed endometriosis.

Close to 60% Revenue Contribution is by EU5, US and Japan

The endometriosis treatment market is a consolidated market space in terms of geography, where regions have a certain market share according to the awareness and adoption of endometriosis treatment. Countries, where proper healthcare infrastructure, routine awareness for self-hygiene, and women health initiatives are present, tend to deliver in the endometriosis treatment market. The U.S., Japan, U.K., Germany, France, Spain, and Italy are estimated to contribute around 60% of the entire revenue from the endometriosis treatment market. This is primarily due to the awareness for endometriosis conditions resent in this region.

endometriosis treatment market

Competitive Landscape

The report provides a competitive landscape present in the endometriosis treatment market. The study involves data on each manufacturer having their product for endometriosis treatment in the market or present in clinical phase. The study involves complete data on each market player in the endometriosis treatment market. Companies like AbbVie Inc., Bayer AG, AstraZeneca, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Ipsen Pharma, Myovant Sciences Ltd, Endoceutics, Inc., Debiopharm Group and Mayne Pharma Group Limited are included in the study. The report provides data, as in manufacturer’s revenue, comparative strategies, members, and latest development on key strategies in the concerned market. Comprehensive analyst opinion on endometriosis treatment drugs provided by each company is also provided separately.

About the Report

The market study on endometriosis treatment was recently published by the company. This report provides inclusive information about the important factors instrumental in the growth of the endometriosis treatment market during 2018-2028. Readers can find other inclusions in this market which are important in order to drive the market and state the reasons for its existence. Most accurate quantitative and qualitative information about the growth of endometriosis treatment product manufacturers is present.

Segmentation

The company’s report on the endometriosis treatment market provides an in-depth information on the current market scenario. The endometriosis treatment market is segmented by geographical region, drug type, treatment type, and distribution channel. This provides a vigorous segment-wise analysis and growth reasons for each segment in the endometriosis treatment market. Based on geographical region, the endometriosis treatment market is segmented into five regions – North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Exc. China, China, and Middle East & Africa (MEA). By product type, the market is segmented into Oral Contraceptives, Progestins, NSAIDs, GnRH Analogues, LNR-IUDs, and Others. Depending on the treatment type, the endometriosis treatment market is segmented into hormonal therapy and pain management. By distribution channel, the endometriosis treatment market is segmented into hospital pharmacies, retail pharmacies, drugstores, and e-commerce.

Additional Questions Answered

This report consists of information crucial to the endometriosis treatment market. The readers can find factors providing dynamics to the endometriosis treatment, be it demand side or supply side. Certain valuable insights might help in solving critical questions for the endometriosis treatment market, such as:

  • Which drug type accounts for the maximum demand?

  • Is off-label purchasing present for all of the drug types in endometriosis treatment?

  • Why developed countries account for the maximum share in the endometriosis treatment market?

  • Which are the prominent strategies applied by manufacturers in this endometriosis treatment market?

Research Methodology

The process of market estimation is followed by different working strategies. Endometriosis treatment involves drugs which are mostly sold off label. These are precisely mapped over a period. Endometriosis treatment adoption is derived by assuming the potential and present market prevalence of the condition and filters are added to estimate the no. of prevalent population. Adoption of each drug type counter with alternate surgical procedure is applied to get volume treatments. The company does an extensive secondary research of the endometriosis treatment market. Industry-validated historical and current data about the demand for endometriosis treatment across the globe is included. Comprehensive secondary research is followed by extensive and in-depth primary research, where detailed information about the endometriosis treatment market is obtained in terms of value (US$ Million). Based on thorough secondary and primary research, analysts come up with the most precise growth parameters for the endometriosis treatment market that would lead the forecast and assumption factors.

A recent market study published by the company – 'Endometriosis Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028', consists of an inclusive assessment of the most important market dynamics on endometriosis with assessed medications. The company has done some direct research on the principle structure of the endometriosis treatment market. A direct market overview provides the growth scenarios and market potential with maximum precision, and adjudged with suitable assumptions. The report features unique and relevant factors that may have a huge impact on the development of the endometriosis treatment market during the forecast period. This report includes a detailed and considerable amount of inclusion, which would help new manufacturers with the most comprehensive way for better understanding

Chapter 1 – Executive Summary

The report commences with the executive summary of the endometriosis treatment market report, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) for leading segments in the endometriosis treatment market.

Chapter 2 – Market Introduction

Readers can find a detailed market structure and definition of endometriosis treatment and drug types, in this chapter, which helps in understanding the basic information about the endometriosis treatment market. The definition section considers the factors included and excluded for the purpose of this report.

Chapter 3 – Market Overview

Readers can find the outlook of the global endometriosis treatment market, considering various factors associated with the growth, which would help in tracking the market’s current scenario, with key inferences drawn from historical data, current trends, and future prospects. Macro-economic factors influencing the market are also discussed in this segment. A brief understanding of the global healthcare sector is also provided in this section.

Chapter 4– Market Dynamics

This chapter highlights the key market dynamics, including drivers, restraints, opportunities, and trends. In this chapter, readers can understand factors that are propelling the growth of the market, along with factors that may deter the growth of the market. Also, readers will understand the key trends followed by leading manufacturers in the endometriosis treatment market.

Chapter 5 – Endometriosis Treatment Market: Key Inclusions

Key pointers such as pipeline drug analysis and new medical treatments for endometriosis are also included in this endometriosis treatment market report.

Chapter 6 – North America Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the North America endometriosis treatment market, along with a country-wise assessment of the U.S. and Canada. Readers can also find historical trends and market attractiveness based on drug type, treatment type, distribution channel, and country in the North American region.

Chapter 7 – Latin America Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the Latin America endometriosis treatment market, along with a country-wise assessment, including Brazil and Mexico. Market attractiveness based on various segments is provided for the Latin American region.

Chapter 8 – Western Europe Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

Important growth prospects of the endometriosis treatment market can be found with market attractiveness based on drug type, treatment type, and distribution channel. European countries such as Germany, France, Italy, Spain, and the U.K. are included in this chapter for industry analysis.

Chapter 9 – Eastern Europe Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the Eastern Europe endometriosis treatment market, along with a country-wise assessment, including Russia and Poland. Market attractiveness based on various segments is provided for the Eastern European region.

Chapter 10 – APEC Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

India, Australia & New Zealand, and Japan are the leading countries/regions in the Asia Pacific region that are assessed to obtain the growth prospects of the APEC endometriosis treatment market in this chapter. Readers can find thorough information about the growth parameters. Market attractiveness based drug type, treatment type, and distribution channel for endometriosis treatment in the APEC region is also provided in this section.

Chapter 11 – China Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter includes detailed analysis of the growth of the China endometriosis treatment market. Market attractiveness based drug type, treatment type, and distribution channelis present for this region

Chapter 12 – MEA Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This chapter provides information on how the endometriosis treatment market will grow in major countries of the MEA region, such as GCC Countries and South Africa, during the period 2018-2028.

Chapter 13 – Forecast Factors: Relevance and Impact

This chapter providesforecast factors for relevance in building the market value for the endometriosis treatment market

Chapter 14 – Competitive Assessment

This chapter includes a comprehensive list of all the leading manufacturers in the endometriosis treatment market, along with detailed information about each company, including company overview, revenue share, strategic overview, and recent company developments. Market players featured in the report include AbbVie Inc., Bayer AG, AstraZeneca, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Ipsen Pharma, Myovant Sciences Ltd, Endoceutics, Inc., Debiopharm Group and Mayne Pharma Group Limited

Chapter 15 – Global Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Region

This section highlights endometriosis treatment in the overall global market by value (US$ Mn) forecast and analysis, by region.

Chapter 16 – Global Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Drug Type

Based on drug type market analysis, the endometriosis treatment market is segmented into oral contraceptives, progestins, NSAIDs, GnRH analogues, LNR-IUDs, and others.

Chapter 17 – Global Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Treatment Type

Based on treatment type, the endometriosis treatment market is segmented into hormonal therapy and pain management.

Chapter 18 – Global Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Distribution Channel

Based on distribution channel, the endometriosis treatment market is segmented into hospital pharmacies, retail pharmacies, drugstores, and e-Commerce.

Chapter 19 – Global Endometriosis Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028

This section highlights the overall global market value (US$ Mn) forecast and analysis of the endometriosis treatment market, with detailed incremental opportunity and absolute opportunity.

Chapter 20 – Assumptions and Acronyms Used

This section consists of a glossary of the assumptions and acronyms used in the endometriosis treatment market report.

Chapter 21 – Research Methodology

This chapter helps readers understand the research methodology that is followed to obtain various conclusions, important qualitative information, and quantitative information about the endometriosis treatment market.

Endometriosis Treatment Market Reports - Table of Contents

  1. Executive Summary

    • Market Overview

    • Market Analysis

    • FMI Analysis and Recommendations

    • Wheel of Fortune

  2. Market Introduction

    • Market Taxonomy

    • Market Definition

  3. Market Overview

    • Market Scenario

    • Macroeconomic Assumptions

    • Global Healthcare Market Outlook

  4. Market Background

    • Market Dynamics

      • Drivers

      • Restraints

      • Opportunity

      • Trends

  5. Key Inclusion

    • Pipeline assessment

    • Action of New Treatments.

    • Potential diagnostic biomarkers for endometriosis

  6. North America Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) Analysis By Country, 2013–2017

      • U.S.

      • Canada

    • Market Size (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017

      • Oral Contraceptives

      • Progestins

      • NSAIDs

      • GnRH Analogues

      • LNR-IUDs

      • Others

    • Market Size (US$ Mn) Forecast By Drug Type, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Treatment type , 2013–2017

      • Hormonal Therapy

      • Pain management

    • Market Size (US$ Mn) Forecast By Treatment type , 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Drugstores

      • E-commerce

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Drug Type

      • By Treatment type

      • By Distribution Channel

    • Drivers and Restraints – Impact Analysis

  7. Latin America Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) By Country, 2013–2017

      • Brazil

      • Mexico

      • Rest of Latin America

    • Market Size (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017

      • Oral Contraceptives

      • Progestins

      • NSAIDs

      • GnRH Analogues

      • LNR-IUDs

      • Others

    • Market Size (US$ Mn) Forecast By Drug Type, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Treatment type, 2013–2017

      • Hormonal Therapy

      • Pain management

    • Market Size (US$ Mn) Forecast By Treatment type, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Drugstores

      • E-commerce

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Drug Type

      • By Treatment type

      • By Distribution Channel

    • Drivers and Restraints – Impact Analysis

  8. Western Europe Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) By Country, 2013–2017

      • Germany

      • France

      • U.K.

      • Spain

      • Italy

      • Rest of Western Europe

    • Market Size (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017

      • Oral Contraceptives

      • Progestins

      • NSAIDs

      • GnRH Analogues

      • LNR-IUDs

      • Others

    • Market Size (US$ Mn) Forecast By Drug Type, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Treatment type , 2013–2017

      • Hormonal Therapy

      • Pain management

    • Market Size (US$ Mn) Forecast By Treatment type , 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Drugstores

      • E-commerce

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Drug Type

      • By Treatment type

      • By Distribution Channel

    • Drivers and Restraints – Impact Analysis

  9. Eastern Europe Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) By Country, 2013–2017

      • Russia

      • Poland

      • Rest of Eastern Europe

    • Market Size (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017

      • Oral Contraceptives

      • Progestins

      • NSAIDs

      • GnRH Analogues

      • LNR-IUDs

      • Others

    • Market Size (US$ Mn) Forecast By Drug Type, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Treatment type , 2013–2017

      • Hormonal Therapy

      • Pain management

    • Market Size (US$ Mn) Forecast By Treatment type , 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Drugstores

      • E-commerce

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Drug Type

      • By Treatment type

      • By Distribution Channel

    • Drivers and Restraints – Impact Analysis

  10. Asia Pacific excluding China (APEC) Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) By Country, 2013–2017

      • India

      • Japan

      • Australia and New Zealand

      • Rest of APEC

    • Market Size (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017

      • Oral Contraceptives

      • Progestins

      • NSAIDs

      • GnRH Analogues

      • LNR-IUDs

      • Others

    • Market Size (US$ Mn) Forecast By Drug Type, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Treatment type , 2013–2017

      • Hormonal Therapy

      • Pain management

    • Market Size (US$ Mn) Forecast By Treatment type , 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Drugstores

      • E-commerce

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Drug Type

      • By Treatment type

      • By Distribution Channel

    • Drivers and Restraints – Impact Analysis

  11. China Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017

      • Oral Contraceptives

      • Progestins

      • NSAIDs

      • GnRH Analogues

      • LNR-IUDs

      • Others

    • Market Size (US$ Mn) Forecast By Drug Type, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Treatment type , 2013–2017

      • Hormonal Therapy

      • Pain management

    • Market Size (US$ Mn) Forecast By Treatment type , 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Drugstores

      • E-commerce

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Drug Type

      • By Treatment type

      • By Distribution Channel

    • Drivers and Restraints – Impact Analysis

  12. MEA Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028

    • Introduction

    • Historical Market Size (US$ Mn) By Country, 2013–2017

      • GCC Countries

      • South Africa

      • Rest of MEA

    • Market Size (US$ Mn) Forecast By Country, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017

      • Oral Contraceptives

      • Progestins

      • NSAIDs

      • GnRH Analogues

      • LNR-IUDs

      • Others

    • Market Size (US$ Mn) Forecast By Drug Type, 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Treatment type , 2013–2017

      • Hormonal Therapy

      • Pain management

    • Market Size (US$ Mn) Forecast By Treatment type , 2018–2028

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Drugstores

      • E-commerce

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis

      • By Country

      • By Drug Type

      • By Treatment type

      • By Distribution Channel

    • Drivers and Restraints – Impact Analysis

  13. Forecast Factors: Relevance and Impact

  14. Competition Analysis

    • Competition Dashboard

    • Company Deep Dive

      • AbbVie Inc.

        • Overview

        • Financial

        • Product and Treatment type Portfolio

        • Strategy

          • Marketing Strategy

          • Product Strategy

          • Channel Strategy

      • Bayer AG

      • AstraZeneca

      • Pfizer Inc.

      • Teva Pharmaceutical Industries Ltd.

      • Ipsen Pharma

      • Myovant Sciences

      • Endoceutics, Inc.

      • Debiopharm Group

      • Mayne Pharma Group Limited

  15. Global Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Region

    • Introduction / Key Findings

    • Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017

      • North America

      • Western Europe

      • Eastern Europe

      • Latin America

      • Asia Pacific excluding China

      • China

      • Middle East and Africa

    • Market Size (US$ Mn) Forecast By Region, 2018–2028

    • Market Attractiveness Analysis By Region

  16. Global Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Drug Type

    • Introduction

    • Historical Market Size (US$ Mn) and Trend Analysis By Drug Type, 2013–2017

      • Oral Contraceptives

      • Progestins

      • NSAIDs

      • GnRH Analogues

      • LNR-IUDs

      • Others

    • Market Size (US$ Mn) Forecast By Drug Type, 2018–2028

    • Market Attractiveness Analysis By Drug Type

  17. Global Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Treatment type

    • Introduction

    • Historical Market Size (US$ Mn) Trend Analysis By Treatment type , 2013–2017

      • Hormonal Therapy

      • Pain management

    • Market Size (US$ Mn) Forecast By Treatment type , 2018–2028

    • Market Attractiveness Analysis By Treatment type

  18. Global Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

    • Introduction

    • Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017

      • Hospital Pharmacies

      • Retail Pharmacies

      • Drugstores

      • E-commerce

    • Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2028

    • Market Attractiveness Analysis By Distribution Channel

  19. Global Endometriosis Treatment Market Analysis 2013–2017 and Forecast 2018–2028

    • Market Value Share Analysis

      • By Country

      • By Drug Type

      • By Treatment type

      • By Distribution Channel

    • Y-o-Y Growth Analysis

      • By Country

      • By Drug Type

      • By Treatment type

      • By Distribution Channel

    • Absolute $ Opportunity

  20. Assumptions and Acronyms Used

  21. Research Methodology

Endometriosis Treatment Market Reports - List of Tables

  1. Expenditure on Health, (% of GDP), by Country, 2016 - 2021

  2. Expenditure on Health, (% of GDP), by Country, 2016 - 2021

  3. New medical treatment of endometriosis.

  4. Potential diagnostic biomarkers for endometriosis

  5. North America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  6. North America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  7. North America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  8. North America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  9. Latin America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  10. Latin America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  11. Latin America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  12. Latin America Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  13. Western Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  14. Western Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  15. Western Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  16. Western Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  17. Eastern Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  18. Eastern Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  19. Eastern Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  20. Eastern Europe Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  21. APEC Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  22. APEC Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  23. APEC Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  24. APEC Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  25. China Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  26. China Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  27. China Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  28. MEA Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Country

  29. MEA Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  30. MEA Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  31. MEA Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

  32. Global Endometriosis Treatment Market Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Region

  33. Global Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Drug Type

  34. Global Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Treatment Type

  35. Global Endometriosis Treatment Market size (US$ Mn) Analysis 2013–2017 and Opportunity Assessment 2018–2028, By Distribution Channel

Endometriosis Treatment Market Reports - List of Figures

  1. Global Overview of Clinical Trails, by Region

  2. Clinical trials of cytotoxics as reported, by Phase

  3. Reported number of study type for each clinical trial

  4. North America Endometriosis Treatment Market Share, By Drug Type, 2018

  5. North America Endometriosis Treatment Market Share, By Treatment Type, 2018

  6. North America Endometriosis Treatment Market Share, By Distribution Channel, 2018

  7. North America Endometriosis Treatment Market Share, By Country, 2018

  8. North America Endometriosis Treatment Market Value US$

  9. North America Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  10. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  11. US Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  12. US Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  13. Canada Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  14. Canada Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  15. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  16. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  17. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  18. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  19. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  20. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  21. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  22. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  23. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  24. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  25. North America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  26. North America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  27. North America Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  28. North America Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  29. North America Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  30. North America Endometriosis Treatment Market Attractiveness Analysis, By Country

  31. Latin America Endometriosis Treatment Market Share, By Drug Type, 2018

  32. Latin America Endometriosis Treatment Market Share, By Treatment Type, 2018

  33. Latin America Endometriosis Treatment Market Share, By Distribution Channel, 2018

  34. Latin America Endometriosis Treatment Market Share, By Country, 2018

  35. Latin America Endometriosis Treatment Market Value US$

  36. Latin America Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  37. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  38. Brazil Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  39. Brazil Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  40. Mexico Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  41. Mexico Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  42. Rest of Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  43. Rest of Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  44. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  45. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  46. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  47. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  48. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  49. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  50. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  51. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  52. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  53. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  54. Latin America Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  55. Latin America Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  56. Latin America Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  57. Latin America Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  58. Latin America Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  59. Latin America Endometriosis Treatment Market Attractiveness Analysis, By Country

  60. Western Europe Endometriosis Treatment Market Share, By Drug Type, 2018

  61. Western Europe Endometriosis Treatment Market Share, By Treatment Type, 2018

  62. Western Europe Endometriosis Treatment Market Share, By Distribution Channel, 2018

  63. Western Europe Endometriosis Treatment Market Share, By Country, 2018

  64. Western Europe Endometriosis Treatment Market Value US$

  65. Western Europe Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  66. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  67. U.K Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  68. U.K Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  69. Germany Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  70. Germany Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  71. Spain Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  72. Spain Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  73. Italy Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  74. Italy Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  75. France Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  76. France Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  77. Rest of Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  78. Rest of Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  79. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  80. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  81. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  82. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  83. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  84. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  85. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  86. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  87. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  88. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  89. Western Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  90. Western Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  91. Western Europe Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  92. Western Europe Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  93. Western Europe Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  94. Western Europe Endometriosis Treatment Market Attractiveness Analysis, By Country

  95. Eastern Europe Endometriosis Treatment Market Share, By Drug Type, 2018

  96. Eastern Europe Endometriosis Treatment Market Share, By Treatment Type, 2018

  97. Eastern Europe Endometriosis Treatment Market Share, By Distribution Channel, 2018

  98. Eastern Europe Endometriosis Treatment Market Share, By Country, 2018

  99. Eastern Europe Endometriosis Treatment Market Value US$

  100. Eastern Europe Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  101. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  102. Russia Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  103. Russia Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  104. Poland Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  105. Poland Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  106. Rest of Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  107. Rest of Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  108. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  109. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  110. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  111. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  112. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  113. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  114. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  115. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  116. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  117. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  118. Eastern Europe Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  119. Eastern Europe Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  120. Eastern Europe Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  121. Eastern Europe Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  122. Eastern Europe Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  123. Eastern Europe Endometriosis Treatment Market Attractiveness Analysis, By Country

  124. APEC Endometriosis Treatment Market Share, By Drug Type, 2018

  125. APEC Endometriosis Treatment Market Share, By Treatment Type, 2018

  126. APEC Endometriosis Treatment Market Share, By Distribution Channel, 2018

  127. APEC Endometriosis Treatment Market Share, By Country, 2018

  128. APEC Endometriosis Treatment Market Value US$

  129. APEC Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  130. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  131. India Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  132. India Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  133. Australia & NZ Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  134. Australia & NZ Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  135. Japan Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  136. Japan Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  137. Rest of APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  138. Rest of APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  139. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  140. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  141. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  142. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  143. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  144. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  145. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  146. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  147. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  148. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  149. APEC Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  150. APEC Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  151. APEC Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  152. APEC Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  153. APEC Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  154. APEC Endometriosis Treatment Market Attractiveness Analysis, By Country

  155. China Endometriosis Treatment Market Share, By Drug Type, 2018

  156. China Endometriosis Treatment Market Share, By Treatment Type, 2018

  157. China Endometriosis Treatment Market Share, By Distribution Channel, 2018

  158. China Endometriosis Treatment Market Value US$

  159. China Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  160. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  161. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  162. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  163. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  164. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  165. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  166. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  167. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  168. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  169. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  170. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  171. China Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  172. China Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  173. China Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  174. China Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  175. China Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  176. MEA Endometriosis Treatment Market Share, By Drug Type, 2018

  177. MEA Endometriosis Treatment Market Share, By Treatment Type, 2018

  178. MEA Endometriosis Treatment Market Share, By Distribution Channel, 2018

  179. MEA Endometriosis Treatment Market Share, By Country, 2018

  180. MEA Endometriosis Treatment Market Value US$

  181. MEA Endometriosis Treatment Market size (US$ Mn) Analysis, 2013–2017

  182. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  183. South Africa Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  184. South Africa Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  185. GCC Countries Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  186. GCC Countries Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  187. Rest of MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017

  188. Rest of MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  189. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Oral Contraceptives

  190. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Oral Contraceptives

  191. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Progestins

  192. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Progestins

  193. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, NSAIDs

  194. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, NSAIDs

  195. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, GnRH Analogues

  196. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, GnRH Analogues

  197. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, LNR-IUDs

  198. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, LNR-IUDs

  199. MEA Endometriosis Treatment Market Size (US$ Mn) Analysis, 2013–2017, Others

  200. MEA Endometriosis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, Others

  201. MEA Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  202. MEA Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  203. MEA Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  204. MEA Endometriosis Treatment Market Attractiveness Analysis, By Country

  205. Global Endometriosis Treatment Market value Share, By Region, 2018-2028

  206. Global Endometriosis Treatment Market Y-o-Y Growth (%), , By Region, 2017-2028

  207. Global Endometriosis Treatment Market Attractiveness Analysis, By Region

  208. Global Endometriosis Treatment Market value Share, By Drug Type, 2018-2028

  209. Global Endometriosis Treatment Market Attractiveness Analysis, By Drug Type

  210. Global Endometriosis Treatment Market Analysis, By Treatment Type

  211. Global Endometriosis Treatment Market Attractiveness Analysis, By Treatment Type

  212. Global Endometriosis Treatment Market value share, By Distribution Channel. 2018-2028

  213. Global Endometriosis Treatment Market Attractiveness Analysis, By Distribution Channel

  214. Global Endometriosis Treatment Industry Value Analysis US$ 2017-2028

  215. Global Endometriosis Treatment Market Absolute $ Opportunity (US$ Mn), 2013–2017

  216. Global Endometriosis Treatment Market Absolute $ Opportunity (US$ Mn), 2017–2028